Fischer Medical Ventures' Q3 FY 2025-26 Quarterly Results
- 31 Jan 2026
Result Summary
- Fischer Medical Ventures Ltd reported a 15.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 742.4%.
- Its expenses for the quarter were up by 13.2% QoQ and 581.3% YoY.
- The net profit increased 38.3% QoQ and decreased 6731.0% YoY.
- The earnings per share (EPS) of Fischer Medical Ventures Ltd stood at 0.29 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 102.18 | 88.79 | 12.13 | 15.1% | 742.4% |
Total Expenses | 80.94 | 71.48 | 11.88 | 13.2% | 581.3% |
Profit Before Tax | 21.25 | 17.30 | 0.25 | 22.8% | 8400.0% |
Tax | 1.95 | 3.37 | 0.42 | -42.1% | 364.3% |
Profit After Tax | 19.23 | 13.90 | -0.29 | 38.3% | -6731.0% |
Earnings Per Share | 0.29 | 2.11 | -0.05 | -86.3% | -680.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Fischer Medical Ventures Ltd is a company operating within the healthcare sector, primarily focusing on providing medical solutions and services. The company is involved in the development and distribution of medical devices and healthcare technologies. While specific details about recent developments or the company's exact market positioning are not available, Fischer Medical Ventures Ltd is likely engaged in innovation within the medical field, given its industry context. The company's operations are geared towards addressing healthcare needs, which may include the production of medical equipment, diagnostic tools, or healthcare software solutions. Any recent developments specific to the company are not available in the provided data.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Fischer Medical Ventures Ltd reported a total income of ₹102.18 crores. This represents a quarter-over-quarter increase of 15.1% compared to ₹88.79 crores in the second quarter of the same fiscal year (Q2FY26). Year-over-year, the company's total income surged by 742.4% from ₹12.13 crores in the third quarter of the previous fiscal year (Q3FY25). This significant increase in revenue over the year indicates a substantial growth in the company's business operations or market reach during this period, as reflected in the financial data provided.
Profitability
For Q3FY26, Fischer Medical Ventures Ltd recorded a profit before tax of ₹21.25 crores, which is a 22.8% increase from the ₹17.30 crores reported in Q2FY26. Year-over-year, the profit before tax rose dramatically by 8400.0% from ₹0.25 crores in Q3FY25. The tax expense for Q3FY26 was ₹1.95 crores, showing a decrease of 42.1% from Q2FY26's ₹3.37 crores, yet a 364.3% increase from ₹0.42 crores in Q3FY25. The profit after tax for the latest quarter was ₹19.23 crores, marking a 38.3% increase quarter-over-quarter from ₹13.90 crores. Year-over-year, this figure rose significantly from a loss of ₹0.29 crores in Q3FY25, reflecting a notable turnaround in profitability. Earnings per share (EPS) stood at ₹0.29, a decline from ₹2.11 in Q2FY26, but an improvement from a loss of ₹0.05 in Q3FY25.
Operating Metrics
During Q3FY26, the total expenses for Fischer Medical Ventures Ltd were ₹80.94 crores, a 13.2% increase from ₹71.48 crores in Q2FY26. Compared to the same quarter last year, where expenses were ₹11.88 crores, there was a substantial year-over-year increase of 581.3%. These increases in expenditure may reflect expanded operational activities or increased investment in business processes. Despite the rise in expenses, the company's profitability improved on both a quarterly and annual basis. The company's ability to generate higher revenue while managing its expenses effectively has contributed to its improved financial performance in this quarter.